Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Greaves, Ronda / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter


IMPACT FACTOR 2017: 3.556

CiteScore 2017: 2.34

SCImago Journal Rank (SJR) 2017: 1.114
Source Normalized Impact per Paper (SNIP) 2017: 1.188

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 38, Issue 8

Issues

Apolipoprotein E Polymorphism and Serum Concentration in Alzheimer's Disease in Nine European Centres: the ApoEurope Study

Gerard Siest / Philippe Bertrand / Bin Qin / Bernard Herbeth / Jean-Marie Serot / Luis Masana / Josep Ribalta / A. Peter Passmore / Alun Evans / Maurizio Ferrari / Massimo Franceschi / James Shepherd / Marina Cuchel / Ulrike Beisiegel / Katrin Zuchowsky / Ana Stavljenic Rukavina / Jadranka Sertic / Marina Stojanov / Vladimir Kostic / Angel Mitrevski / Vera Petrova / Catherine Sass / Aksam Merched / Jukka T. Salonen / Laurence Tiret / Sophie Visvikis / the ApoEurope group13
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/CCLM.2000.102

Abstract

As part of the ApoEurope Project, apolipoprotein E (apo E) common polymorphism and serum concentration were determined in 489 Alzheimer's disease patients and 429 controls. Patients and controls were recruited through nine centres in eight European countries. Age, sex ratios and education levels of both case and control populations were similar, although discrete differences appeared between centres. The prevalence of the ε4 allele was higher in Alzheimer's disease than in controls (increased by 140%), while serum apo E concentration was lower by 11.2% (p<0.001). In addition, serum total cholesterol and triglyceride concentrations were lower in Alzheimer's disease (p<0.001), while that of apo AI was not affected. The decrease in serum apo E concentration was not accounted for by the ε4 allele, age or gender, suggesting that apo E concentration might represent an additional risk factor for Alzheimer's disease, complementary and independent of the ε4 allele. Further analysis will be aimed at determining whether the quantitative link between apo E concentration and Alzheimer's disease occurs through the effect of apo E genotype on lipid parameters or by other mechanisms.

About the article

Published Online: 2005-06-01

Published in Print: 2000-08-21


Citation Information: Clinical Chemistry and Laboratory Medicine, Volume 38, Issue 8, Pages 721–730, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2000.102.

Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[2]
T. Xie, S. Akbar, M.G. Stathopoulou, T. Oster, C. Masson, F.T. Yen, and S. Visvikis-Siest
Neurobiology of Aging, 2018
[3]
Z. Wang, W. Qin, C.B. Wei, Y. Tang, L.N. Zhao, H.M. Jin, Y. Li, Q. Wang, X.Q. Luan, J.C. He, and J. Jia
International Journal of Geriatric Psychiatry, 2018
[4]
Xiaochen Huang, Shengqi Dong, Jie Zhen, Huiqiang Zhang, Tong Lin, Yuhong Zeng, Nicholas Van Halm-Lutterodt, and Linhong Yuan
Frontiers in Endocrinology, 2018, Volume 9
[5]
Sun-Ho Han, Jun Seok Kim, Youngju Lee, Heesun Choi, Jong-Won Kim, Duk Lyul Na, Eun Gyeong Yang, Myeong-Hee Yu, Daehee Hwang, Cheolju Lee, and Inhee Mook-Jung
Molecular & Cellular Proteomics, 2014, Volume 13, Number 2, Page 407
[6]
Petra Majerova, Peter Barath, Alena Michalicova, Stanislav Katina, Michal Novak, and Andrej Kovac
Journal of Alzheimer's Disease, 2017, Volume 58, Number 2, Page 507
[7]
Fei Song, Anne Poljak, John Crawford, Nicole A. Kochan, Wei Wen, Barbara Cameron, Ora Lux, Henry Brodaty, Karen Mather, George A. Smythe, Perminder S. Sachdev, and Stephen D. Ginsberg
PLoS ONE, 2012, Volume 7, Number 6, Page e34078
[8]
Chong Wang, Jin-Tai Yu, Hui-Fu Wang, Teng Jiang, Chen-Chen Tan, Xiang-Fei Meng, Holly D. Soares, Lan Tan, and David R. Borchelt
PLoS ONE, 2014, Volume 9, Number 2, Page e89041
[10]
Daniela Scarabino, Elisabetta Broggio, Giuseppe Gambina, Carlotta Maida, Maria Rosa Gaudio, and Rosa Maria Corbo
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2016, Volume 171, Number 8, Page 1131
[11]
Vivian P. Lara, Paulo Caramelli, Antônio L. Teixeira, Maira T. Barbosa, Karoline C. Carmona, Henrique C. Guimarães, Maria G. Carvalho, Ana P. Fernandes, and Karina B. Gomes
Journal of Clinical Laboratory Analysis, 2016, Volume 30, Number 5, Page 374
[12]
Dilek Inekci, Ditte Svendsen Jonesco, Sophie Kennard, Morten Asser Karsdal, and Kim Henriksen
Frontiers in Neurology, 2015, Volume 6
[13]
Katrine L. Rasmussen, Anne Tybjaerg-Hansen, Børge G. Nordestgaard, and Ruth Frikke-Schmidt
Annals of Neurology, 2015, Volume 77, Number 2, Page 301
[14]
Norman Salem, Milene Vandal, and Frederic Calon
Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA), 2015, Volume 92, Page 15
[15]
Abdul Hye, Joanna Riddoch-Contreras, Alison L. Baird, Nicholas J. Ashton, Chantal Bazenet, Rufina Leung, Eric Westman, Andrew Simmons, Richard Dobson, Martina Sattlecker, Michelle Lupton, Katie Lunnon, Aoife Keohane, Malcolm Ward, Ian Pike, Hans Dieter Zucht, Danielle Pepin, Wei Zheng, Alan Tunnicliffe, Jill Richardson, Serge Gauthier, Hilkka Soininen, Iwona Kłoszewska, Patrizia Mecocci, Magda Tsolaki, Bruno Vellas, and Simon Lovestone
Alzheimer's & Dementia, 2014, Volume 10, Number 6, Page 799
[17]
Mary Jo LaDu, Gregory W. Munson, Lisa Jungbauer, Godfrey S. Getz, Catherine A. Reardon, Leon M. Tai, and Chunjiang Yu
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2012, Volume 1821, Number 2, Page 295
[18]
Brigitte Leininger-Muller, Aline Hoy, Bernard Herbeth, Michèle Pfister, Jean-Marie Serot, Marina Stavljenic-Rukavina, Luis Massana, P Passmore, Gérard Siest, and Sophie Visvikis
Neuroscience Letters, 2003, Volume 349, Number 2, Page 95
[19]
Vincenzo Solfrizzi, Alessia D'Introno, Anna Maria Colacicco, Cristiano Capurso, Orlando Todarello, Vincenza Pellicani, Sabrina A Capurso, Giuseppe Pietrarossa, Vito Santamato, Antonio Capurso, and Francesco Panza
Clinica Chimica Acta, 2006, Volume 364, Number 1-2, Page 91
[20]
Ricarda Thier, Thomas Brüning, Peter H. Roos, Hans-Peter Rihs, Klaus Golka, Yon Ko, and Hermann M. Bolt
International Journal of Hygiene and Environmental Health, 2003, Volume 206, Number 3, Page 149
[21]
Michael C. Irizarry
NeuroRX, 2004, Volume 1, Number 2, Page 226
[22]
C.E. Teunissen, J. de Vente, H.W.M. Steinbusch, and C. De Bruijn
Neurobiology of Aging, 2002, Volume 23, Number 4, Page 485
[23]
C.E. Teunissen, D. Lütjohann, K. von Bergmann, F. Verhey, F. Vreeling, A. Wauters, E. Bosmans, H. Bosma, M.P.J. van Boxtel, M. Maes, J. Delanghe, H.J. Blom, M.M. Verbeek, P. Rieckmann, C. De Bruijn, H.W.M. Steinbusch, and J. de Vente
Neurobiology of Aging, 2003, Volume 24, Number 7, Page 893
[24]
Richard A Frank, Douglas Galasko, Harald Hampel, John Hardy, Mony J de Leon, Pankaj D Mehta, Joseph Rogers, Eric Siemers, and John Q Trojanowski
Neurobiology of Aging, 2003, Volume 24, Number 4, Page 521
[25]
Francesco Panza, Alessia D'Introno, Anna Maria Colacicco, Cristiano Capurso, Gianfranco Pichichero, Sabrina A. Capurso, Antonio Capurso, and Vincenzo Solfrizzi
Brain Research Reviews, 2006, Volume 51, Number 2, Page 275
[26]
Josep Ribalta, Joan-Carles Vallvé, Josefa Girona, and Lluís Masana
Current Opinion in Clinical Nutrition and Metabolic Care, 2003, Volume 6, Number 2, Page 177
[27]
Gérard Siest, Philippe Bertrand, Bernard Herbeth, Monique Vincent-Viry, Françoise Schiele, Catherine Sass, and Sophie Visvikis
Clinical Chemistry and Laboratory Medicine, 2000, Volume 38, Number 9
[28]
Stoyan Danev and Drozdstoy St. Stoyanov
Folia Medica, 2010, Volume 52, Number 2
[29]
G. Zuliani, M. Cavalieri, M. Galvani, S. Volpato, A. Cherubini, S. Bandinelli, A. M. Corsi, F. Lauretani, J. M. Guralnik, R. Fellin, and L. Ferrucci
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 2010, Volume 65A, Number 5, Page 559
[30]
J. J. Jalbert, L. A. Daiello, and K. L. Lapane
Epidemiologic Reviews, 2008, Volume 30, Number 1, Page 15
[31]
Anna Juhász, Ágnes Rimanóczy, Krisztina Boda, Gábor Vincze, Győző Szlávik, Marianna Zana, Annamária Bjelik, Magdolna Pákáski, Nikoletta Bódi, András Palotás, Zoltán Janka, and János Kálmán
Neurochemical Research, 2005, Volume 30, Number 8, Page 943
[32]
International Journal of Geriatric Psychiatry, 2001, Volume 16, Number 2, Page 240
[33]
G�rard Siest, Mohamed Zaiou, and Sophie Visvikis
Drug Development Research, 2002, Volume 56, Number 2, Page 95

Comments (0)

Please log in or register to comment.
Log in